Ann Lee Cahill, VP Clinical Development at VION PHARMACEUTICALS INC (VION), sold 70,000 shares at $0.78 ($55K) on 2009-09-08, disclosed to the SEC on 2009-09-10.
Open-market sale of $55k VION by VP Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.